Literature DB >> 18508403

Immune regulation and control of regulatory T cells by OX40 and 4-1BB.

Takanori So1, Seung-Woo Lee, Michael Croft.   

Abstract

The TNFR family members OX40 (CD134) and 4-1BB (CD137) have been found to play major roles as costimulatory receptors for both CD4 and CD8 T cells. In particular, in many situations, they can control proliferation, survival, and cytokine production, and hence are thought to dictate accumulation of protective T cells during anti-viral and anti-tumor responses and pathogenic T cells during autoimmune reactions. As opposed to simply controlling the activity of naïve, effector, and memory T cells, recent data have suggested that both molecules are also instrumental in controlling the generation and activity of so-called regulatory or suppressor T cells (Treg), perhaps in both positive and negative manners. Part of the action on Treg might function to further promote protective or pathogenic T cells, but alternate activities of OX40 and 4-1BB on Treg are also being described that suggest that there might be control by these molecules at multiple levels that will alter the biological outcome when these receptors are ligated. This review specifically focuses on recent studies of regulatory T cells, and regulatory or suppressive activity, that are modulated by OX40 or 4-1BB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508403      PMCID: PMC2486494          DOI: 10.1016/j.cytogfr.2008.04.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  60 in total

1.  Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering.

Authors:  Lara Myers; Chikara Takahashi; Robert S Mittler; Robert J Rossi; Anthony T Vella
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-14       Impact factor: 11.205

2.  Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis.

Authors:  Yonglian Sun; Xiaoqi Lin; Helen M Chen; Qiang Wu; Sumit K Subudhi; Lieping Chen; Yang-Xin Fu
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

3.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

4.  Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease.

Authors:  Yonglian Sun; Helen M Chen; Sumit K Subudhi; Jonathan Chen; Rima Koka; Lieping Chen; Yang-Xin Fu
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

5.  Immune responses in 4-1BB (CD137)-deficient mice.

Authors:  Byoung S Kwon; Jose C Hurtado; Zang H Lee; Kyu B Kwack; Su K Seo; Beom K Choi; Beverly H Koller; Godwin Wolisi; Hal E Broxmeyer; Dass S Vinay
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

6.  OX40 costimulation turns off Foxp3+ Tregs.

Authors:  Minh Diem Vu; Xiang Xiao; Wenda Gao; Nicolas Degauque; Ming Chen; Alexander Kroemer; Nigel Killeen; Naoto Ishii; Xian Chang Li
Journal:  Blood       Date:  2007-06-15       Impact factor: 22.113

7.  Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.

Authors:  Kutlu G Elpek; Esma S Yolcu; Deanna D H Franke; Chantale Lacelle; Rich-Henry Schabowsky; Haval Shirwan
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

8.  Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced by anti-4-1BB monoclonal antibody.

Authors:  Seong-A Ju; Sang-Min Park; Sang-Chul Lee; Byoung S Kwon; Byung-Sam Kim
Journal:  Mol Cells       Date:  2007-08-31       Impact factor: 5.034

9.  In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

Authors:  Franck J Barrat; Daniel J Cua; André Boonstra; David F Richards; Chad Crain; Huub F Savelkoul; René de Waal-Malefyt; Robert L Coffman; Catherine M Hawrylowicz; Anne O'Garra
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation.

Authors:  Micah J Benson; Karina Pino-Lagos; Mario Rosemblatt; Randolph J Noelle
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307

View more
  46 in total

Review 1.  Costimulatory and coinhibitory receptors in anti-tumor immunity.

Authors:  Gregory Driessens; Justin Kline; Thomas F Gajewski
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 2.  TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

3.  Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.

Authors:  Eun Jee Kim; Jae Geun Lee; Joon Ye Kim; Seung Hwan Song; Dong Jin Joo; Kyu Ha Huh; Myoung Soo Kim; Beom Seok Kim; Yu Seun Kim
Journal:  Immunology       Date:  2017-08-23       Impact factor: 7.397

Review 4.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

5.  The upregulated expression of OX40/OX40L and their promotion of T cells proliferation in the murine model of asthma.

Authors:  Wei Lei; Da-Xiong Zeng; Can-Hong Zhu; Gao-Qin Liu; Xiu-Qin Zhang; Chang-Guo Wang; Qin Wang; Jian-An Huang
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

6.  Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier.

Authors:  Aruna Bitra; Tzanko Doukov; Michael Croft; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

Review 7.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

Review 8.  Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions.

Authors:  Farhad Jadidi-Niaragh; Ghasem Ghalamfarsa; Mehdi Yousefi; Mina Hajifaraj Tabrizi; Fazel Shokri
Journal:  Tumour Biol       Date:  2013-05-17

9.  Hypercostimulation through 4-1BB distorts homeostasis of immune cells.

Authors:  Seung-Woo Lee; Shahram Salek-Ardakani; Robert S Mittler; Michael Croft
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

Review 10.  The significance of OX40 and OX40L to T-cell biology and immune disease.

Authors:  Michael Croft; Takanori So; Wei Duan; Pejman Soroosh
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.